Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1,009

Website

www.dizalpharma.com

Country

China

Exchange

Shanghai

Founded 2017

Dizal (Jiangsu) Pharmaceutical Co., Ltd., a commercial-stage biopharmaceutical company, discovers develops, and commercializes therapeutics for the treatment of oncology and hematologic disorders.

Its assets include the ZEGFROVY, for the treatment of solid tumors. Its portfolio also includes Gao Ruizhe to treat hematological malignancy, solid tumors, and immunological diseases, Birelentinib indicated for hematological malignancy, DZD2269, DZD1516, and DZD6008 for solid tumors, and GW5282 for hematological malignancy and solid tumors. Founded in 2017, Dizal (Jiangsu) Pharmaceutical is based in Shanghai, China.

Key Stats

52-Week Range

¥35.73¥86.18

Beta0.04

Trailing P/EN/A

Forward P/E75.24

Trailing EPS-1.46

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.